Your browser doesn't support javascript.
loading
Extra­abdominal recurrent aggressive fibromatosis: A case series and a literature review.
Asaad, Saywan K; Abdullah, Ari M; Abdalrahman, Shkar Ali; Fattah, Fattah H; Tahir, Soran H; Omer, Choman Sabah; Rashid, Rezheen J; Hassan, Marwan N; Mohammed, Shvan H; Kakamad, Fahmi H; Abdalla, Berun A.
Afiliação
  • Asaad SK; Department of Scientific Affairs, Smart Health Tower, Sulaimani, Kurdistan 46001, Iraq.
  • Abdullah AM; College of Medicine, University of Sulaimani, Sulaimani, Kurdistan 46001, Iraq.
  • Abdalrahman SA; Department of Scientific Affairs, Smart Health Tower, Sulaimani, Kurdistan 46001, Iraq.
  • Fattah FH; Sulaimani Teaching Hospital, Sulaimani, Kurdistan 46001, Iraq.
  • Tahir SH; Department of Surgery, Shar Hospital, Sulaimani, Kurdistan 46001, Iraq.
  • Omer CS; Department of Scientific Affairs, Smart Health Tower, Sulaimani, Kurdistan 46001, Iraq.
  • Rashid RJ; College of Medicine, University of Sulaimani, Sulaimani, Kurdistan 46001, Iraq.
  • Hassan MN; Department of Scientific Affairs, Smart Health Tower, Sulaimani, Kurdistan 46001, Iraq.
  • Mohammed SH; College of Medicine, University of Sulaimani, Sulaimani, Kurdistan 46001, Iraq.
  • Kakamad FH; Department of Scientific Affairs, Smart Health Tower, Sulaimani, Kurdistan 46001, Iraq.
  • Abdalla BA; Department of Scientific Affairs, Smart Health Tower, Sulaimani, Kurdistan 46001, Iraq.
Mol Clin Oncol ; 19(4): 84, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37808248
ABSTRACT
Aggressive fibromatosis is a rare clonal proliferative tumor arising from mesenchymal cells in the fascia and musculoaponeurotic structures. The aim of the present study was to describe several cases of extra-abdominal recurrent aggressive fibromatosis. The present study was a single-center retrospective case series of patients with recurrent aggressive fibromatosis. The cases were managed at a single private facility. A total of 9 patients with recurrent fibromatosis were included. The mean and median ages of the patients were 29 and 30 years, respectively. In total, two thirds (66.67%) of the cases were female. A negative previous medical history was reported in 7 cases (77.7%), and diabetes and hypertension were reported in 1 case (11.1%). Overall, only 1 case (11.1%) had a family history of breast fibromatosis. The time interval between primary tumor resection and recurrent presentation was 28 months. In 6 cases (66.7%), the tumor was located in the extremities. Pain was the most common presenting symptom in 6 cases (66.7%). All patients had their recurring tumor surgically removed, followed by radiation in 5 cases. The resection margin was positive in 4 cases (44.4%). Each patient was subjected to a careful three-month follow-up for recurrences. On the whole, the present study demonstrates that despite the fact that several therapeutic approaches for extra-abdominal recurrent aggressive fibromatosis have been described in the literature, there is a significant likelihood of recurrence following resection.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Clin Oncol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Clin Oncol Ano de publicação: 2023 Tipo de documento: Article